Thursday, February 9, 2012 Last update: 6:33 PM
The Best of U.S. Company Technology News

Abbott

News articles for Abbott:

Wednesday, February 8, 2012

  • Abbott Creates New Similac SimplySmart(TM) Baby Bottle with Innovative Features
    ABBOTT PARK, Ill., Feb. 8, 2012 /PRNewswire/ -- Abbott (NYSE: ABT) introduces Similac SimplySmart, an innovative BPA-free baby bottle designed to improve the bottle feeding experience for parents and babies through advanced features that provide comfort and convenience. This unique bottle, designed by experts in infant nutrition, incorporates insights from moms ... read more

Wednesday, February 1, 2012

Wednesday, January 25, 2012

Wednesday, January 18, 2012

Wednesday, January 4, 2012

Thursday, December 22, 2011

Monday, December 19, 2011

Thursday, December 15, 2011

  • Abbott to Present at J.P. Morgan Healthcare Conference
    ABBOTT PARK, Ill., Dec. 15, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the 30th Annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 10, 2012. Thomas C. Freyman, executive vice president, finance and chief financial officer, will make a formal presentation on the company at ... read more

Monday, December 12, 2011

Friday, December 9, 2011

  • Abbott Declares 352nd Consecutive Quarterly Dividend
    ABBOTT PARK, Ill., Dec. 9, 2011 /PRNewswire/ -- The board of directors of Abbott <font size="2" face="Arial">(NYSE: ABT)</font> today declared a quarterly common dividend of 48 cents per share. This marks the 352nd consecutive quarterly dividend to be paid by Abbott since 1924. The cash dividend is ... read more

Thursday, December 8, 2011

Wednesday, November 30, 2011

  • Abbott Receives FDA Clearance for New Test to Detect Vitamin D Levels
    ABBOTT PARK, Ill., Nov. 30, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) announced today it has received clearance from the U.S. Food and Drug Administration for a fully-automated 25-OH Vitamin D assay performed on its widely used ARCHITECT(®) laboratory testing platform. Published data from the Third National Health ... read more

Monday, November 28, 2011

Monday, November 21, 2011

Tuesday, November 15, 2011

  • Abbott Statement on the Results of the AIM-HIGH Study Presented at AHA 2011
    ORLANDO, Fla., Nov. 15, 2011 /PRNewswire/ -- Final results were presented today from the AIM-HIGH study, a National Heart, Lung and Blood Institute (NHLBI) study. The study was designed to test whether raising HDL "good" cholesterol by adding Niaspan to simvastatin would provide an additional 25 percent reduction in cardiovascular ... read more

Monday, November 14, 2011

Tuesday, November 8, 2011

Monday, November 7, 2011

Sunday, November 6, 2011

Thursday, November 3, 2011

  • Abbott to Present New Data for Key Vascular Products at TCT 2011
    ABBOTT PARK, Ill., Nov. 3, 2011 /PRNewswire/ -- Abbott (NYSE: ABT) today announced the company's schedule of key data presentations at the 23rd annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, to be held Nov. 7 - 11 in San Francisco. New data will be presented on two of Abbott's key ... read more